Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 12Active not recruiting 3Recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Lymphoma 8Leukemia, Myeloid, Acute 8Multiple Myeloma 6Myelodysplastic Syndromes 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Chronic-Phase 5Neuroblastoma 4Hodgkin Disease 4Graft vs Host Disease 4Congenital Abnormalities 4Recurrence 3Neoplasms, Plasma Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Lymphocytic, Chronic, B-Cell 3Burkitt Lymphoma 3Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2

Interventions

Cyclophosphamide 4Vincristine 2Thioguanine 2Prednisolone 2Mitoxantrone 2Methotrexate 2Mercaptopurine 2Melphalan 2Leucovorin 2Hydrocortisone 2Etoposide 2Daunorubicin 2Cytarabine 2Cord Blood Stem Cell Transplantation 2Asparaginase 2sargramostim 1pegaspargase 1fludarabine phosphate 1Whole-Body Irradiation 1Vindesine 1Therapeutics 1Tacrolimus 1Rituximab 1Psychiatric Rehabilitation 1Prednisone 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone 1Levofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Biphenotypic, Acute × Busulfan × Clear all
NCT00550992 2019-07-30

Interfant06

Dutch Childhood Oncology Group

Phase NA Unknown
445 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡